BIOTE CORP BTMD
CLASS A COM · Common Stock · CUSIP 090683103
- SectorHealth care
- IndustryMedicinal Chemicals & Botanical Products
- HeadquartersIrving, TX
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($348.0k this quarter). Holder counts are more reliable. Implied quarter-end price ≈ $4.24. Options: 1 managers hold calls ($214.0k notional), 0 hold puts (—).
Biggest calls
| Paloma Partners Management Co | — | $214.0k50.0k shares |
Biggest puts
| None |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Roystone Management Holdings LLC
13D · may seek influence
new · filed 2025-06-12
Stated purposeThe Reporting Persons originally acquired the Common Stock for investment purposes. The Reporting Persons are filing this initial Schedule 13D to report that Richard Barrera, managing member of the Manager, was appointed to the Issuer's board of directors (the "Board") on June 5, 2025. For more information, please see the Issuer's Current Report on Form 8-K, filed with the SEC on June 9, 2025, which is incorporated herein by reference. Except as otherwise set forth herein, the Reporting Persons do not have any present plans or proposals which would relate to, or result in, the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D. However, subject to market conditions and in compliance with applicable securities laws, the Reporting Persons reserve the right, at a later … Full filing |
14.0% |
| Roystone Capital Management LP 13G · passive investor filed 2025-03-18 | 12.0% |
| AGARWAL AMIT MOHAN 13G · passive investor +0.8 pts · filed 2026-09-18 | 8.4% |
| Bandera Partners LLC 13G · passive investor filed 2026-05-13 | 6.4% |
Fell to 5% or below in the last year: BlackRock, Inc. (1.2%, 2026-07-27)
Insider purchases and sales in Q3 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q3 2022.
Holders, Q3 2022
| Manager | Shares | Change |
|---|---|---|
| Cohanzick Management, LLC 0.87% of their portfolio | 842.1k $3.6m | — |
| Venator Capital Management Ltd. 1.68% of their portfolio | 204.6k $876.0k | — |
| Diametric Capital, LP 0.35% of their portfolio | 164.1k $702.0k | — |
| Meteora Capital, LLC 0.10% of their portfolio | 95.0k $407.0k | — |
| WASATCH ADVISORS LP 0.00% of their portfolio | 94.9k $406.0k | — |
| PRELUDE CAPITAL MANAGEMENT, LLC 0.02% of their portfolio | 91.4k $391.0k | — |
| RiverPark Advisors, LLC 0.11% of their portfolio | 81.3k $348.0k | — |
| BOOTHBAY FUND MANAGEMENT, LLC 0.01% of their portfolio | 75.0k $321.0k | — |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 59.9k $256.0k | — |
| BBR PARTNERS, LLC 0.03% of their portfolio | 46.2k $198.0k | — |
| Pitti Group Wealth Management, LLC 0.14% of their portfolio | 24.6k $105.0k | — |
| Tilden Park Management I LLC 0.11% of their portfolio | 18.8k $6.0k | — |
| Creative Planning 0.00% of their portfolio | 11.6k $50.0k | — |
| UBS Group AG 0.00% of their portfolio | 2.0k $9.0k | — |
| MORGAN STANLEY 0.00% of their portfolio | 2.0k $9.0k | — |
| WOLVERINE ASSET MANAGEMENT LLC 0.00% of their portfolio | 876 $3.0k | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |